Pregnancy Flashcards
Naegele’s rule for EDD
first day of LMP + 7 days + 1 year - 3 months
Common medications that are teratogenic
ACEi/ARB warfarin anti-epileptics carbimazole methotrexate isotretinoin lithium
Components to assess during palpation of abdomen /uterus
SFH uterine tone and tenderness lie presentation position engagement liquor volume
Causes of bHCG levels being higher/lower than expected
higher: multiple gestation, molar pregnancy, trisomy 21
lower: ectopic, miscarriage
both: wrong dates
Major complications of pregnancy
Pre term labour IUGR GDM Miscarriage or stillbirth Antepartum or PPH Pre eclampsia
“PIGMAP”
Pre-conception care
Hx: HPC, Obs and gyn hx, PMHx, teratogenic medications, Social (SNAP, home), FHx
Exam: vitals, anthropometry, systems review, breast and cervical screening
Ix: bloods (FBC, blood typing, BBV infections, vaccine serology), urine dipstick, HPV swab
Lifestyle: SNAP and weight loss
Avoid TORCH organisms: avoid raw meats/seafood, cold cheese, cat litter, wash hands, etc
Supplements: folate and iodine
Vaccines: Influenza, dTPa, MMRV
Risk factors for foetal abnormality
- foetal/pregnancy and maternal factors
Maternal:
- previous hx of foetal abnormality
- increasing age
- teratogens
- maternal disease
Foetal/pregnancy:
- IUGR
- abnormal amniotic fluid
- persistent breech or abnormal lie
- abnormal foetal movements
Routine antenatal screening tests for foetal abnormalities
what is considered high risk
CFTS: 11-14 weeks, bHCG, PAPP-A + USS nuchal translucency
2nd trimester screen: 14-18 weeks, bHCG + AFP + UE-3 + inhibin-A
> 1/300 combined risk = high risk = offered diagnostic testing
What is cfDNA / NIPT? aka harmony test
cell free DNA / non invasive prenatal testing
alternative to CFTS to detect aneuploidy ie chromosome abnormalities in 21, 18, 13
measures cell free DNA from placenta in maternal plasma
more specific and sensitive but still requires diagnostic testing
$400 self funded
Diagnostic antenatal tests
chorionic villus sampling (CVS)
- 11-14 weeks, placental biopsy
amniocentesis
- >15 weeks
risks: spontaneous foetal loss
What does carrier screening test for and when is it done?
CF
spinal muscular atrophy
fragile X
before conception or 1st trimester
Definition of antepartum haemorrhage
> 20 weeks gestation but before birth
Examination of APH
general - LOC, pallor, pain, estimate blood loss by inspecting groin area
Vitals - haemodynamically stable
abdominal - inspect, SFH, palpate foetal lie, uterine tone and tenderness, CTG
pelvic - inspect only! do NOT do bimanual, obstetrician may do speculum
Ix and Mx for APH
mother - FBC, coagulation, G&H, cross match
Foetus - transabdominal USS, CTG
medical - TXA, betamethasone IM, anti-D if Rh-
Types of placenta praaevia
1 - <2cm from cervical os but clear of os
2 - margin of os
3 - overlying os, part of placenta in upper uterus
4 - covering os, entirely in lower segment
RF for placenta praaevia
hx of placenta praaevia past c section multiparous fibroids multiple pregnancy
what is low lying placenta and what is the management
low lying placenta = <2cm from os and <26/40
high grade or accreta - F/U 32/40
low grade - F/U 36/40
safety net
accreta - MRI
symptoms and exam features of placenta praaevia bleeding
symptoms - painless antenatal vaginal haemorrhage, sudden onset, recurrent bleeding
exam - soft abdomen with normal uterine tone, foetal parts easy to palpate, malpresentation of foetus (transverse or oblique, displaced presenting part to high and central)
Management of placenta praaevia during third trimester ie counselling, plan, mx
counselling
- low lying, blocking passage of baby
- 2 concerns - massive bleeding, baby cannot get out
- close monitoring required
- C section at 37/40
- +/- blood transfusion
- +/- hysterectomy
admit for monitoring until 37/40
Rx - betamethasone IM if <34/40, replace iron and blood as required
What is placenta accreta and what is the management
placenta implantation over previous c section scar
management similar to placenta praaevia but with higher risk of bleeding
more likely to require hysterectomy due to inability to separate placenta